| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $81.2M | — | +10.5% |
| R&D Expense | $13.6M | — | +12.9% |
| SG&A Expense | $13.0M | — | +6.7% |
| Operating Income | $7.5M | — | +71.6% |
| Pre-tax Income | $7.8M | — | +49.0% |
| Income Tax | $1.9M | — | +108.5% |
| Net Income | $5.9M | — | +36.4% |
| EPS (Basic) | $0.20 | — | +42.9% |
| EPS (Diluted) | $0.20 | — | +42.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $48.7M | +34.7% | -37.0% |
| Accounts Receivable | $38.4M | +19.5% | +24.6% |
| Current Assets | $133.0M | +11.2% | -21.6% |
| Total Assets | $527.4M | +1.4% | +0.6% |
| Current Liabilities | $136.5M | +10.0% | +8.5% |
| Stockholders' Equity | $352.0M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $27.1M | — | +0.2% |
| Capital Expenditures | $740K | — | -29.9% |
| Investing Cash Flow | -$6.3M | — | +12.9% |
| Financing Cash Flow | -$8.3M | — | -314.0% |
| Free Cash Flow | $26.4M | — | +1.4% |
| -3.0% |